MINISTER FOR HEALTH AND FAMILY WELFARE; MINISTER FOR SCIENCE AND TECHNOLOGY; AND MINISTER OF EARTH SCIENCES
(DR. HARSH VARDHAN)
(a) & (b) Yes, congenital and hereditary genetic diseases are a significant health burden in India. Based on the data published in the journal ‘Community Genetics’ (2002; 5 (3): 192-6), an estimated 495,000 infants with congenital malformations, 390,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with ß-thalassaemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders are born each year in the country. Considering these facts, National Policy for Treatment of Rare Diseases was announced in June 2017 by Ministry of Health & family Welfare, Govt. of India. However, in the light of new information and updates available for further improvement and effective implementation, Central Govt. has decided to review this policy and through Gazette notification dated 18.12.2018 kept this policy in abeyance till the revised policy is issued by the Central Govt. or till further order whichever is earlier.
(c) Yes, the Department of Biotechnology (DBT), Govt. of India has recently launched Unique Methods of Management of Inherited Disorders (UMMID) initiative with the objectives i) to establish Genetic Diagnostic Units in Government Hospitals wherein the influx of patients is more, ii) to produce skilled clinicians in the area of Human Genetics, and iii) to do pilot scale screening of pregnant women and new born babies for diagnostics of inherited genetic diseases in some aspirational districts to provide comprehensive clinical care (diagnosis, management, multidisciplinary care, counselling, prenatal testing).
(d) & (e) Under UMMID initiative, following projects have been sanctioned as a pilot initiative:
(i) Five Genetics Labs- NIDAN Kendras (National Inherited Disorders AdministratioN Kendras) have been sanctioned to provide comprehensive clinical care including diagnosis, management, multidisciplinary care, counseling, prenatal testing at following Government hospitals
S. No. State Implementing Institution Sanctioned cost (Rs. in Crores) Released amount (Rs. in Crores)
1. West Bengal NRS Medical College, Kolkata 1.50 0.81
2. Rajasthan AIIMS Jodhpur 1.47 1.15
3. Delhi Army Hospital Research & Referrals, New Delhi 1.41 1.08
4. Delhi Lady Harding’s Medical College, New Delhi 4.58 2.19
5. Telangana NIMS, Hyderabad 1.58 1.19
(ii) Seven Training Centres at following institutions/ hospitals have been supported to provide training in Biochemical Genetics, Cytogenetics, Molecular Genetics, Clinical Genetics and Comprehensive clinical care to the clinicians working in Government hospitals
S. No. State Implementing Institution Sanctioned cost (Rs. in Crores) Released amount (Rs. in Crores)
1. Tamil Nadu Madras Medical Mission, Chennai 0.48 0.28
2. Uttar Pradesh SGPGIMS, Lucknow 3.95 1.48
3. Telangana CDFD, Hyderabad 3.95 1.48
4. Delhi AIIMS, New Delhi 4.41 1.68
5. Delhi MAMC, New Delhi 4.41 1.55
6. Maharashtra NIIH, Mumbai 3.95 1.48
7. Tamil Nadu CMC, Vellore 3.93 1.73
(iii) Under the program, seven Aspirational Districts namely Mewat, Haryana; Yadgir, Karnataka; Haridwar, Uttarakhand; Washim & Nandurbar, Maharashtra; Ranchi, Jharkhand; Shrawasti, Uttar Pradesh have been identified for screening of 10,000 pregnant women and 5000 new born babies per year in each districts for diagnostics of inherited genetic diseases to provide comprehensive clinical care including diagnosis, management, multidisciplinary care, counseling, prenatal testing.
(f) Nidan Kendras established and clinicians trained through UMMID initiative will cater to the need of treating and preventing diseases caused by genetic disorders across the country.
****
Download PDF Files